Evidence map›Paper›PMID 34121160›Full record

ArticleEnvironmental science and pollution research international2021

A new approach on synergistic effect and chemical stability of graphene oxide-magnetic nanocomposite in the heterogeneous Fenton degradation of caffeine.

Manuel Alejandro Ramirez-Ubillus, Nayara de Melo Costa-Serge, Peter Hammer, Raquel Fernandes Pupo Nogueira

Erratum issuedOpen access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Environmental science and pollution research international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 9 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Manuel Alejandro Ramirez-UbillusInstitute of Chemistry, São Paulo State University (UNESP), Araraquara, SP, 14800-900, Brazil.
Nayara de Melo Costa-SergeInstitute of Chemistry, São Paulo State University (UNESP), Araraquara, SP, 14800-900, Brazil.
Peter HammerInstitute of Chemistry, São Paulo State University (UNESP), Araraquara, SP, 14800-900, Brazil.
Raquel Fernandes Pupo NogueiraInstitute of Chemistry, São Paulo State University (UNESP), Araraquara, SP, 14800-900, Brazil. raquel.pupo@unesp.br.ORCID http://orcid.org/0000-0003-1237-4571
Universidade Estadual Paulista (Unesp) · BRCentro Universitário de Araraquara · BR

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 465571/2014-0Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 88887136426/2017/00Fundação de Amparo à Pesquisa do Estado de São Paulo 2014/50945-4Fundação de Amparo à Pesquisa do Estado de São Paulo 2018/17517-0
6 · The paper itself

Abstract

Two compositions of graphene oxide-magnetite nanocomposites were studied as catalysts in the heterogeneous Fenton process. Transmission electron microscopy and X-ray diffraction revealed that the graphene oxide sheets were covered with nanoparticles of magnetite, with an average crystallite size of 7 nm. Infrared spectroscopy analysis indicated that the phases interacted through covalent Fe-O-C bonds. The composites presented significantly improved catalytic activity, compared to pure magnetite, with a synergistic effect of up to a factor of 17.1 for the Fenton degradation of caffeine, achieving total removal after 90 min. This synergistic effect was a consequence of the interaction between the phases, resulting in improved mass transfer of caffeine to the catalyst surface, adsorption and efficient degradation, with enhanced HO

Indexed as

CaffeineNanocompositesGraphiteMagnetic PhenomenaPhysicsCaffeinegraphene oxideGraphiteEnhanced kineticGraphene oxideMagnetitePharmaceuticalRadical reactionSurface reaction

Identifiers

PMID34121160
OpenAlexW3167576731

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.